K
Kevin Schwartzman
Researcher at McGill University Health Centre
Publications - 61
Citations - 5038
Kevin Schwartzman is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 30, co-authored 48 publications receiving 4552 citations. Previous affiliations of Kevin Schwartzman include McGill University & BC Centre for Disease Control.
Papers
More filters
Journal ArticleDOI
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention
Jean Bourbeau,Marcel Julien,François Maltais,Michel Rouleau,Alain Beaupré,Raymond Bégin,P Renzi,Diane Nault,Elizabeth M. Borycki,Kevin Schwartzman,Ravinder Singh,Jean Paul Collet +11 more
TL;DR: A continuum of self-management for COPD patients provided by a trained health professional can significantly reduce the utilization of health care services and improve health status.
Journal ArticleDOI
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention
Jean Bourbeau,Marcel Julien,François Maltais,Michel Rouleau,A Beaupre,Bégin R,P Renzi,Diane Nault,Elizabeth M. Borycki,Kevin Schwartzman,R Singh,Jean-Paul Collet,Susan Tiukinhoy,Carolyn L. Rochester +13 more
TL;DR: A continuum of self-management for COPD patients provided by a trained health professional can significantly reduce the utilization of health care services and improve health status.
Journal ArticleDOI
Yield of laboratory testing to identify secondary contributors to Osteoporosis in otherwise healthy women
Cara Tannenbaum,Julie Clark,Kevin Schwartzman,Kevin Schwartzman,Sylvan Wallenstein,Robert H. Lapinski,Diane E. Meier,Marjorie M. Luckey +7 more
TL;DR: The purpose in this study was to determine the prevalence of undetected disorders of bone and mineral metabolism in women with osteoporosis and to identify the most useful and cost-efficient screening tests to detect these disorders.
Journal ArticleDOI
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
Dick Menzies,Menonli Adjobimey,Rovina Ruslami,Anete Trajman,Oumou Sow,Hee Jin Kim,Joseph Obeng Baah,Guy B. Marks,Richard Long,Vernon Hoeppner,Kevin Elwood,Hamdan Al-Jahdali,M. Gninafon,Lika Apriani,Raspati C Koesoemadinata,Afranio Lineu Kritski,Valeria Cavalcanti Rolla,Boubacar Bah,Alioune Camara,Isaac Boakye,Victoria J. Cook,Hazel Goldberg,Chantal Valiquette,Karen Hornby,Marie-Josée Dion,Pei-Zhi Li,Philip C. Hill,Kevin Schwartzman,Andrea Benedetti +28 more
TL;DR: The 4‐ month regimen of rifampin was not inferior to the 9‐month regimen of isoniazid for the prevention of active tuberculosis and was associated with a higher rate of treatment completion and better safety.
Journal ArticleDOI
Self-management reduces both short- and long-term hospitalisation in COPD.
Gadoury Ma,Kevin Schwartzman,Michel Rouleau,François Maltais,Marcel Julien,A Beaupre,P Renzi,Bégin R,Diane Nault,Jean Bourbeau +9 more
TL;DR: Patients with chronic obstructive pulmonary disease who received educational intervention with supervision and support based on disease-specific self-management maintained a significant reduction in hospitalisations after a 2-year period.